Bionano Genomics to Lay Off 84 Employees, Including CFO; Shares Down Pre-Bell
Bionano Genomics (BNGO) said Monday it is laying off about 45% of its workforce, or 84 employees including Chief Financial Officer Gulsen Kama, as part of a broader cost-cutting plan.
The layoffs are expected to be done by Oct. 1, Bionano said, adding that the move is incremental to the company's target of saving $25 million to $30 million in annual operating expenses by Q4.
Bionano said Kama will step down by Sept. 18 as part of the staff reduction. Chief Executive Erik Holmlin and finance executive Mark Adamchak will take over the company's finance and accounting departments until a new CFO is appointed, Bionano added.
Shares of the company were down 4.5% in recent Tuesday premarket activity.
Price: 0.4251, Change: -0.02, Percent Change: -4.47
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。